Cargando…

The Alteration of Plasma Matrix Metalloproteinase-9 Level after the Addition of Bromelin 500 mg to Standard Therapy of Acute Ischemic Stroke and Its Correlation with Outcome

BACKGROUND: Matrix metalloproteinase-9 (MMP9) expression due to ischemic cause spreading of brain damage. Previous studies have reported that Bromelin was beneficial as anti-inflammation and prevent brain tissue damage. AIM: This study aimed to determine the alteration of plasma MMP9 level after add...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sinurat, Puji Pinta, Sjahrir, Hasan, Rambe, Aldy S., Ganie, Ratna Akbari
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Republic of Macedonia 2018
Materias:	Clinical Science
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5927490/ https://www.ncbi.nlm.nih.gov/pubmed/29731927 http://dx.doi.org/10.3889/oamjms.2018.151

Ejemplares similares

Tumour Necrosis Factor-Α, Interleukin-1 and Interleukin-6 Serum Levels and Its Correlation with Pain Severity in Chronic Tension-Type Headache Patients: Analysing Effect of Dexketoprofen Administration
por: Rambe, Aldy Safruddin, et al.
Publicado: (2017)

Predictive Model of Diabetic Polyneuropathy Severity Based on Vitamin D Level
por: Fitri, Aida, et al.
Publicado: (2019)

Use of honey associated with Ananas comosus (Bromelin) in the treatment of acute irritative cough
por: Peixoto, Décio Medeiros, et al.
Publicado: (2016)

The Levels of Vitamin D, Metalloproteinase-9 and Tissue Inhibitor Metalloproteinase-1 in COPD Patients, Healthy Smokers and Non-Smokers of Indonesian Citizens
por: Arbaningsih, Sri Rezeki, et al.
Publicado: (2019)

Correlation between the Montreal Cognitive Assessment-Indonesian Version (Moca-INA) and the Mini-Mental State Examination (MMSE) in Elderly
por: Rambe, Aldy Safruddin, et al.
Publicado: (2017)

Correlation between Lymphocyte CD4 Count, Treatment Duration, Opportunistic Infection and Cognitive Function in Human Immunodeficiency Virus-Acquired Immunodeficiency Syndrome (HIV-AIDS) Patients
por: Fitri, Fasihah Irfani, et al.
Publicado: (2018)

The Role of Matrix Metalloproteinase Polymorphisms in Ischemic Stroke
por: Chang, Jason J., et al.
Publicado: (2016)

Clopidogrel Resistance Among Ischemic Stroke Patients and Its Risk Factors in Indonesia
por: Hidayat, Rakhmad, et al.
Publicado: (2022)

Role of Matrix Metalloproteinase-9 in Neonatal Hypoxic-Ischemic Encephalopathy
por: Salah, Mohab M., et al.
Publicado: (2019)

Brand versus generic dispensing trend for ciprofloxacin 500 mg, levofloxacin 500 mg, and moxifloxacin 400 mg (oral dosage forms) among pharmacies of Karachi, Pakistan
por: Zehra, Fatima, et al.
Publicado: (2017)

Matrix Metalloproteinases and Blood-Brain Barrier Disruption in Acute Ischemic Stroke
por: Lakhan, Shaheen E., et al.
Publicado: (2013)

Carnosine Protects against Cerebral Ischemic Injury by Inhibiting Matrix-Metalloproteinases
por: Kim, Eun-Hye, et al.
Publicado: (2021)

PHYSICOCHEMICAL PROPERTIES OF THE PROTEOLYTIC ENZYME FROM THE LATEX OF THE MILKWEED, ASCLEPIAS SPECIOSA TORR. SOME COMPARISONS WITH OTHER PROTEASES : III. KINETICS OF THE HEAT INACTIVATION OF PAPAIN, BROMELIN, AND ASCLEPAIN
por: Winnick, Theodore, et al.
Publicado: (1940)

Final Overall Survival: Fulvestrant 500mg vs 250mg in the Randomized CONFIRM Trial
por: Leo, Angelo Di, et al.
Publicado: (2013)

Turmeric Extract Supplementation Reduces Tau Protein Level in Repetitive Traumatic Brain Injury Model
por: Siahaan, Andre Marolop Pangihutan, et al.
Publicado: (2018)

Association Between Serum Midkine Level and Gastric Precancerous Lesion in Patients with Gastritis
por: Siregar, Jelita, et al.
Publicado: (2022)

Corrigendum: Matrix Metalloproteinases and Blood-Brain Barrier Disruption in Acute Ischemic Stroke
por: Lakhan, Shaheen E., et al.
Publicado: (2018)

Serum Matrix Metalloproteinase‐9 and Cognitive Impairment After Acute Ischemic Stroke
por: Zhong, Chongke, et al.
Publicado: (2018)

Bibliometric and visualization analysis of matrix metalloproteinases in ischemic stroke from 1992 to 2022
por: Gao, YiKun, et al.
Publicado: (2023)

Functional relationship between matrix metalloproteinase-11 and matrix metalloproteinase-14
por: Buache, Emilie, et al.
Publicado: (2014)

Expression of matrix metalloproteinases and tissue inhibitor of matrix metalloproteinases in the hair cycle
por: HOU, CHUN, et al.
Publicado: (2016)

Efficacy and Safety of Terbinafine 500 mg Once Daily in Patients with Dermatophytosis
por: Babu, P Ravindra, et al.
Publicado: (2017)

Matrix metalloproteinases and epileptogenesis
por: Ikonomidou, Chrysanthy
Publicado: (2014)

Matrix Metalloproteinases and Glaucoma
por: Kim, Moo Hyun, et al.
Publicado: (2022)

A Comparison of the Quality of Sleep between Pre and Post-Surgery Cervical Herniated Nucleus Pulposus Patients Utilizing the Anterior Discectomy Method
por: Dharmajaya, Ridha, et al.
Publicado: (2017)

Matrix metalloproteinase-2 gene polymorphisms are associated with ischemic stroke in a Hainan population
por: Niu, Fanglin, et al.
Publicado: (2018)

Involvement of Matrix Metalloproteinase 9 in Vertebral Arterial Dissection With Posterior Circulation Ischemic Stroke
por: Chen, Chun‐Yu, et al.
Publicado: (2020)

Polymorphisms of the Matrix Metalloproteinase Genes are Associated with Acute Ischemic Stroke in Chinese Han Population
por: Li, Aifan, et al.
Publicado: (2023)

Switching from tipranavir (TPV) 500/ritonavir (RTV) 200 mg to TPV 500/RTV 100 mg in treatment-experienced patients (pts) with HIV RNA <50 copies/mL
por: Casado, JL, et al.
Publicado: (2010)

Tipranavir/Ritonavir (500/200 mg and 500/100 mg) Was Virologically Non-Inferior to Lopinavir/Ritonavir (400/100 mg) at Week 48 in Treatment-Naïve HIV-1-Infected Patients: A Randomized, Multinational, Multicenter Trial
por: Cooper, David A., et al.
Publicado: (2016)

Pharmacokinetics, Safety, and Tolerability of a Single 500-mg or 1000-mg Intravenous Dose of Dalbavancin in Healthy Japanese Subjects
por: Scoble, Patrick J., et al.
Publicado: (2015)

DIDS Prevents Ischemic Membrane Degradation in Cultured Hippocampal Neurons by Inhibiting Matrix Metalloproteinase Release
por: Pamenter, Matthew E., et al.
Publicado: (2012)

Matrix Metalloproteinases in Cerebral Ischemia
por: Kim, Hahn Young, et al.
Publicado: (2006)

Matrix metalloproteinases in arthritic disease
por: Murphy, Gillian, et al.
Publicado: (2002)

Matrix metalloproteinases in lung biology
por: Parks, William C, et al.
Publicado: (2001)

Matrix metalloproteinases in exercise and obesity
por: Jaoude, Jonathan, et al.
Publicado: (2016)

Matrix Metalloproteinases and Glaucoma Treatment
por: Weinreb, Robert N., et al.
Publicado: (2020)

Challenges in Matrix Metalloproteinases Inhibition
por: Laronha, Helena, et al.
Publicado: (2020)

Matrix Metalloproteinases in Health and Disease
por: Serra, Raffaele
Publicado: (2020)

Matrix metalloproteinases in keratinocyte carcinomas
por: Riihilä, Pilvi, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_k8ee195c1ruqrndc1dtpikqev7